112 related articles for article (PubMed ID: 37528384)
1. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
2. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
3. METTL1 promotes hepatocarcinogenesis via m
Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
[TBL] [Abstract][Full Text] [Related]
4. Prognostic model and ceRNA network of m7G- and radiosensitivity-related genes in hepatocellular carcinoma.
Liu M; Zhu M; Huang Y; Wu J; Peng Z; Liang Y
Heliyon; 2024 May; 10(9):e29925. PubMed ID: 38707306
[TBL] [Abstract][Full Text] [Related]
5. METTL1 mediated tRNA m
Zhao P; Xia L; Chen D; Xu W; Guo H; Xu Y; Yan B; Wu X; Li Y; Zhang Y; Zhang X
Exp Hematol Oncol; 2024 Jan; 13(1):8. PubMed ID: 38268051
[TBL] [Abstract][Full Text] [Related]
6. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification.
Yue Y; Tao J; An D; Shi L
J Gene Med; 2024 Jan; 26(1):e3611. PubMed ID: 37847055
[TBL] [Abstract][Full Text] [Related]
7. METTL1-mediated tRNA m
Du D; Zhou M; Ju C; Yin J; Wang C; Xu X; Yang Y; Li Y; Cui L; Wang Z; Lei Y; Li H; He F; He J
J Exp Clin Cancer Res; 2024 May; 43(1):154. PubMed ID: 38822363
[TBL] [Abstract][Full Text] [Related]
8. Targeting N
Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
[TBL] [Abstract][Full Text] [Related]
9. Developing risk models and subtypes of autophagy-associated LncRNAs for enhanced prognostic prediction and precision in therapeutic approaches for liver cancer patients.
Zhang LU; Chu J; Yu Y
Oncol Res; 2024; 32(4):703-716. PubMed ID: 38560571
[TBL] [Abstract][Full Text] [Related]
10. METTL1-m
Ying X; Liu B; Yuan Z; Huang Y; Chen C; Jiang X; Zhang H; Qi D; Yang S; Lin S; Luo J; Ji W
Clin Transl Med; 2021 Dec; 11(12):e675. PubMed ID: 34936728
[TBL] [Abstract][Full Text] [Related]
11. The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4.
Yu S; Sun Z; Ju T; Liu Y; Mei Z; Wang C; Qu Z; Li N; Wu F; Liu K; Lu M; Huang M; Pang X; Jia Y; Li Y; Zhang Y; Dou S; Jiang J; Dong X; Huang C; Li W; Zhang Y; Yuan Y; Yang B; Du W
Adv Sci (Weinh); 2024 May; ():e2308769. PubMed ID: 38810124
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma.
Chen J; Zhou Q; Li S; Ling R; Zhao Y; Chen D; Wang A; Cao Y
Transl Res; 2024 Jun; 268():28-39. PubMed ID: 38280546
[TBL] [Abstract][Full Text] [Related]
13. METTL1 facilitates ameloblastoma invasive growth via MAPK signaling pathway.
Wang Y; Xiong G; Cai W; Tao Q
Gene; 2024 May; 905():148234. PubMed ID: 38309318
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Basement Membrane Related LncRNA Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma.
Liu X; Lv C; Zheng J; Xiao J; He N; Du J; Yang X; Gu H
Biochem Genet; 2024 Apr; ():. PubMed ID: 38684626
[TBL] [Abstract][Full Text] [Related]
15. Role of N7-methylguanosine (m
Chen Y; Lin H; Miao L; He J
Trends Cell Biol; 2022 Oct; 32(10):819-824. PubMed ID: 35907701
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Inhibitors of the m7G-RNA Writer METTL1.
Nai F; Flores Espinoza MP; Invernizzi A; Vargas-Rosales PA; Bobileva O; Herok M; Caflisch A
ACS Bio Med Chem Au; 2024 Apr; 4(2):100-110. PubMed ID: 38645929
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
Peng YL; Dong YF; Guo LL; Li MY; Liao H; Li RS
PLoS One; 2023; 18(8):e0289552. PubMed ID: 37535570
[TBL] [Abstract][Full Text] [Related]
18. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.
Qi YN; Liu Z; Hong LL; Li P; Ling ZQ
J Hematol Oncol; 2023 Aug; 16(1):89. PubMed ID: 37533128
[TBL] [Abstract][Full Text] [Related]
19. Clinical plasma cells-related genes to aid therapy in colon cancer.
Zhang Q; Feng X; Zhang M; Sun W; Zhai Y; Qing S; Liu Y; Zhao H; Sun J; Zhang Y; Ma C
BMC Genomics; 2023 Aug; 24(1):430. PubMed ID: 37528394
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of the potential role of necroptosis in hepatocellular carcinoma using single-cell RNA Seq and bulk RNA Seq.
Chen J; Chen C; Tao L; Cai Y; Wang C
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13841-13853. PubMed ID: 37535163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
